When is MHUA's latest earnings report released?
The most recent financial report for Meihua international medical technologies co., ltd. (MHUA) covers the period of 2024Q4 and was published on 2024/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MHUA's short-term business performance and financial health. For the latest updates on MHUA's earnings releases, visit this page regularly.
Where does MHUA fall in the P/E River chart?
According to historical valuation range analysis, Meihua international medical technologies co., ltd. (MHUA)'s current price-to-earnings (P/E) ratio is 2.62, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of MHUA?
According to the latest financial report, Meihua international medical technologies co., ltd. (MHUA) reported an Operating Profit of 8.42M with an Operating Margin of 16.33% this period, representing a growth of 201.88% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is MHUA's revenue growth?
In the latest financial report, Meihua international medical technologies co., ltd. (MHUA) announced revenue of 51.57M, with a Year-Over-Year growth rate of 110.87%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does MHUA have?
At the end of the period, Meihua international medical technologies co., ltd. (MHUA) held Total Cash and Cash Equivalents of 16.9M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does MHUA go with three margins increasing?
In the latest report, Meihua international medical technologies co., ltd. (MHUA) achieved the “three margins increasing” benchmark, with a gross margin of 33.38%%, operating margin of 12.99%%, and net margin of 10.4%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MHUA's profit trajectory and future growth potential.
Is MHUA's EPS continuing to grow?
According to the past four quarterly reports, Meihua international medical technologies co., ltd. (MHUA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.21. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of MHUA?
Meihua international medical technologies co., ltd. (MHUA)'s Free Cash Flow (FCF) for the period is 0, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 100% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
